Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2017 / Article

Research Article | Open Access

Volume 2017 |Article ID 4134093 | 10 pages | https://doi.org/10.1155/2017/4134093

Ziziphus nummularia Inhibits Inflammation-Induced Atherogenic Phenotype of Human Aortic Smooth Muscle Cells

Academic Editor: Alexander N. Orekhov
Received24 Mar 2017
Accepted02 Apr 2017
Published16 May 2017


Cardiovascular disease (CVD) continues to be the leading cause of death worldwide. Atherosclerosis is a CVD characterized by plaque formation resulting from inflammation-induced insults to endothelial cells, monocytes, and vascular smooth muscle cells (VSMCs). Despite significant advances, current treatments for atherosclerosis remain insufficient, prompting the search for alternative modalities, including herbal medicine. Ziziphus nummularia is an herb commonly used in the amelioration of symptoms associated with many health conditions such as cold, diarrhea, cancer, and diabetes. However, its effect on the inflammation-induced behavior of VSMCs remains unknown. In this study, we sought to determine the effect of the ethanolic extract of Z. nummularia (ZNE) on TNF-α-induced phenotypic changes of human aortic smooth muscle cells (HASMCs). The treatment of HASMCs with ZNE decreased cell proliferation, adhesion to fibronectin, migration, and invasion. ZNE treatment also caused a concentration- and time-dependent reduction in the TNF-α-induced expression of matrix metalloproteases MMP-2 and MMP-9, NF-κB, and cell adhesion molecules ICAM-1 and VCAM-1. Furthermore, ZNE decreased the adhesion of THP-1 monocytes to HASMCs and endothelial cells in a concentration-dependent manner. These data provide evidence for the anti-inflammatory effect of Ziziphus nummularia, along with potential implications for its use as an agent that could ameliorate inflammation-induced atherogenic phenotype of VSMCs in atherosclerosis.

1. Introduction

Atherosclerosis is one of the leading causes for morbidity and mortality in Western countries [1]. Major adverse cardiovascular events, including stroke and myocardial infarction, are considered as sequelae of atherosclerosis. Atherosclerotic lesions develop gradually as a result of the accumulation of lipids, foam cells, extracellular matrix, and macrophages within the arterial wall [2]. Proinflammatory signals trigger vascular smooth muscle cells (VSMCs) to switch from a quiescent “contractile” phenotype to a synthetic one [3]. VSMCs release matrix metalloproteinases (MMPs), which are enzymes that allow them to detach from extracellular matrix and migrate to the tunica intima. VSMCs then contribute to the growth of atherosclerotic lesions, due to their ability to proliferate and synthesize extracellular matrix and secrete adhesion molecules that recruit and stabilize inflammatory cells, and might even take up lipids and contribute to foam cell formation [4]. Thus, proliferation and migration of VSMCs are key events in atherosclerosis development.

The leaves of Ziziphus nummularia (Burm.f.) Wight & Arn (family Rhamnaceae) have been widely used in traditional medicine for the treatment of cold, cutaneous diseases, and pain [5, 6]. Phytochemical studies of Z. nummularia extracts revealed the presence of tannins, flavonoids, steroids, glycosides, and alkaloids [7]. The anti-inflammatory activity of Z. nummularia has been illustrated by its ability to promote wound healing [8], reduce inflammatory parameters in multiple in vivo models of inflammation, and reduce nitric oxide and TNF-α production from activated macrophages in vitro [9]. Importantly, an extract of Z. nummularia has been shown to possess DPPH radical scavenging activity [10]. A recent study has also found that the levels of LDL, TG, and VLDL were significantly reduced in diabetic model rats treated with the aqueous and ethanolic extract of Ziziphus nummularia [11]. These observations suggest that Z. nummularia may have a beneficial effect that could ameliorate atherosclerosis, a disease that could be precipitated and exacerbated by inflammation.

In this study, we investigated the effects of the ethanolic extract of Z. nummularia leaves (ZNE) on the proliferation, migration, invasion, and adhesion of HASMCs. Our results demonstrated that ZNE decreased these parameters in HASMCs in a concentration-dependent manner. In addition, the treatment of HASMCs with ZNE inhibited TNF-α-induced MMP-2 and MMP-9 production and increased monocyte adhesion.

2. Materials and Methods

2.1. Cell Culture

Human aortic smooth muscle cells (HASMCs) (Cell Applications, USA) were cultured in DMEM/F12 (50 : 50) and supplemented with L-glutamine, antibiotic/antimycotic cocktail, and 10% fetal bovine serum (FBS). Cells were made quiescent by incubating them in serum-free medium for at least 24 hours prior to any treatment. HUVECs or THP-1 cells (both from American Type Culture Collection, USA) were cultured in RPMI-1640 and supplemented with 10% FBS and 1% penicillin/streptomycin. Cells were maintained in a humidified incubator at 37°C with 5% CO2 atmosphere. Culture media, FBS, L-glutamine, antibiotic/antimycotic, and penicillin/streptomycin were obtained from ThermoFisher Scientific, USA.

2.2. Ziziphus nummularia Extract (ZNE)

The leaves of Ziziphus nummularia were rinsed and air dried in the dark at room temperature. They were then ground into powder and were then suspended in 70% ethanol. The mixture was kept in the dark for 72 hours at 4°C, then filtered. The filtrate was evaporated to dryness using a rotary evaporator at room temperature. The obtained residue was kept at −20°C until further use.

2.3. Cell Counting by Trypan Blue

HASMCs were seeded in 24-well plates and allowed to grow until they reached 30–40% confluency. Cells were then incubated in 0.5% FBS-containing medium for 24 hours. Following this, regular 10% FBS-containing medium was then added along with increasing concentrations of ZNE for 24, 48, or 72 hours. After aspirating media, wells were washed with PBS, and cells were trypsinized followed by counting using a hemocytometer.

2.4. Viability Assay

HASMCs were seeded in 96-well plates and allowed to grow until they reached 30–40% confluency. Cells were then incubated in 0.5% FBS-containing medium for 24 hours. Following this, regular 10% FBS-containing medium was then added along with increasing concentrations of ZNE for 24, 48, or 72 hours. Viability was then determined using CellTiter-Glo assay according to the manufacturer’s protocol (Promega, USA). Briefly, equal volumes of CellTiter-Glo reagent and medium were added to the wells. Plates were mixed by an orbital shaker and incubated at room temperature for 10 minutes to stabilize luminescence signals. The GloMax® 20/20 Luminometer (Promega, USA) was used to assess cell viability, in which luminescence is directly proportional to the number of viable cells.

2.5. Wound Healing or Scratch Assay

HASMCs were seeded in 6-well plates and grown until confluence. They were then incubated in quiescence media (containing 0.5% FBS) for 24 hours. Using a yellow tip (20–200 μl), a scratch was then made. The culture medium was then aspirated, and plates were washed twice with PBS to remove cellular debris. Fresh medium was then added, and cells were incubated in the absence or presence of ZNE. Photomicrographs were taken at baseline (0 hours) and then at 24 hours using the Olympus IX71 inverted microscope. Olympus cellSens® digital imaging software was used to measure the width of the scratch indicative of cell migration.

2.6. Transwell Migration Assay

Cells were seeded onto the upper chamber of a transwell tissue culture plate in serum-free medium, in the absence or presence of ZNE. Regular growth medium (containing 10% FBS) was added in the lower chamber to act as a chemoattractant. After incubation, cells were washed with PBS and fixed. Cells on the upper side of the transwell insert were removed by a cotton-tipped applicator. Cells that have migrated to the lower side of the insert were stained with 1% crystal violet for 10 minutes, followed by washing with PBS. Cells from at least 5 different random fields were counted under the Olympus IX71 inverted microscope.

2.7. Invasion Assay

Invasion assay was performed using Matrigel-coated BD BioCoat™ filter inserts (8 μm pore size, BD Biosciences) as per the manufacturer’s instructions. Briefly, cells in serum-free media were seeded onto the upper transwell chamber in the absence or presence of ZNE. The lower chamber was loaded with regular growth medium (10% FBS) to act as a chemotactic attractant. Cells were then incubated at 37°C for 24 hours. Cells that did not invade the Matrigel were removed from the upper surface with a cotton-tipped applicator; those that have invaded were stained with crystal violet and visualized under the inverted microscope (Olympus IX71).

2.8. Adhesion Assay

Cells were seeded onto fibronectin-coated 96-well plates. Cells were allowed to adhere for 1 hour at 37°C. Nonadherent cells were removed by gentle washing (three times) of the wells using prewarmed PBS. Adherent cells were pictured and counted.

2.9. Measurement of MMP-2 and MMP-9

HASMCs were grown until they reached near confluence. MMP production was induced by exposure to FBS or TNF-α (10 ng/ml) (R&D Systems, USA). For TNF-α, cells were incubated in serum-free media and pretreated with increasing concentrations of ZNE (0, 50, 100,150, and 200 μg/ml) for 30 minutes prior to exposure to TNF-α. In the case of FBS, cells were exposed to ZNE 24 or 48 hours in FBS-supplemented media. In all experiments, conditioned media were collected and subjected to an ELISA for MMP-2 and MMP-9 as per the manufacturer’s protocol (R&D Systems, USA). Experiments were conducted in triplicates, and data are presented as percent of control (vehicle).

2.10. Monocyte Adhesion Assay

The adhesion of THP-1 cells to human umbilical vein endothelial cells (HUVECs) and HASMCs was studied as previously described [12]. Cells were seeded onto collagen-coated plates until confluence, at which point they were treated with increasing concentrations of ZNE for 1 hour. Cells were then incubated with TNF-α (10 ng/ml) for 3 hours. THP-1 cells (labelled with 2′,7′-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein; ThermoFisher Scientific) were added atop the confluent cells and allowed to adhere for 30 minutes. Wells were then washed three times to remove the nonadherent THP-1 cells, and the remaining (adhering) THP-1 cells were examined under a microscope. Fluorescence intensity was measured using a microplate reader at excitation and emission wavelengths of 485 and 528 nm, respectively. The adhesion of THP-1 cells in ZNE-treated wells was calculated by expressing the fluorescent intensity relative to that observed in wells treated only with TNF-α.

2.11. Determination of Expression of Adhesion Molecules by ELISA

The levels of adhesion molecules expressed on the surface of HUVECs was determined by ELISA (Abcam) as previously described with minor modifications [13]. Highly confluent cells were pretreated and incubated with increasing concentrations of ZNE for 2 hours. Cells were then incubated with TNF-α (10 ng/ml) for 8 additional hours. Cells were then washed with PBS and fixed with 4% paraformaldehyde for 30 minutes at 4°C. After washing with PBS, wells were blocked with bovine serum albumin (1.0% in PBS), followed by incubation with ICAM-1, VCAM-1, or isotype-matched control antibodies (diluted in blocking buffer; Abcam) overnight at 4°C. Wells were then washed with PBS and incubated with alkaline phosphatase-conjugated secondary antibody. Wells were then washed with PBS and exposed to the peroxidase substrate p-nitrophenyl phosphate (Sigma Aldrich, USA) (1 mg/ml in 0.1 M glycine buffer, pH 10.4, containing 1 mM MgCl2, and 1 mM ZnCl2). Absorbance was measured at 405 nm, and the values of the isotype-matched control wells were taken as blank.

2.12. Quantitative Real-Time Polymerase Chain Reaction (RT-PCR)

HUVECs were cultured till confluency. They were treated with increasing concertation of ZNE for 30 minutes followed by the addition of TNF-α (10 ng/ml). After (time x), cells were lysed and total RNA was extracted using TRIzol reagent (Invitrogen) according to the manufacturer’s instructions. RNA was then converted into cDNA by reverse transcription, and quantitative real-time PCR was performed using the GoTaq® 2-Step System (Promega). mRNA of ICAM-1 and VCAM-1 was reverse transcribed using the following primers: VCAM-1—forward CCCTTGACCGGCTGGAGATT and reverse CTGGGGGCAACATTGACATAAAGTG; ICAM-1—forward CTGTCACTCGAGATCTTGAGG and reverse CCTGCAGTGCCCATTATGA; and GAPDH—forward ACCCAGAAGACTGTGGATGG and reverse TTCTAGACGGCAGGTCAGGT. Changes in expression levels were calculated with the 2−ΔΔCT method.

2.13. Luciferase Assay

HUVECs were transfected with NF-κB-driven promoter luciferase along with Renilla luciferase vector as an internal control. Transfection and luciferase protocols are discussed previously [14, 15]. Cells were treated with TNF-α alone or with increasing concentrations of ZNE prior to TNF-α treatment. NF-κB expression was quantified by the relative promoter unit and expressed as percentage of expression in cells treated with vehicle alone.

3. Statistical Analysis

Statistical analysis of the data was performed by one-way or two-way ANOVA followed by Dunnett’s, Tukey’s, or Sidak’s tests for multiple comparisons as appropriate using GraphPad Prism Software (GraphPad Software Inc., San Diego, CA). Data were presented as mean ± SEM. A value of less than 0.05 was considered as significant.

4. Results

4.1. ZNE Inhibits FBS-Induced HASMC Proliferation, Migration, and Adhesion to Fibronectin

The inhibitory effects of ZNE on FBS-induced HASMC proliferation were studied using two different assays. Overall, ZNE treatment showed a concentration- and time-dependent inhibition of the FBS-induced HASMC proliferation (Figures 1(a) and 1(b)). In trypan blue exclusion assay (Figure 1(a)), ZNE concentrations of 100, 150, and 200 μg/ml significantly reduced the viable cell number at 24, 48, and 72 hours. The lowest concentration (50 μg/ml), however, causes a significant reduction in cell number only after 48 and 72 hours of ZNE treatment. In the CellTiter assay that measures metabolic activity (which corresponds to viability), only the ZNE concentrations of 150 and 200 μg/ml significantly reduced the viable cell number at 24, 48, and 72 hours (Figure 1(b)).

The ZNE effect on FBS-induced migration of HASMCs was assessed using both scratch and transwell migration assays (Figure 2). ZNE at 100 and 150 μg/ml concentrations significantly decreased FBS-induced HASMC migration from the upper to lower chambers (Figures 2(a) and 2(b)). Similarly, ZNE treatment at both concentrations delayed scratch wound healing compared to vehicle-treated cells (Figures 2(c) and 2(d)).

Because the adhesion of VSMCs to extracellular matrix is important for cell proliferation, migration, and invasion, we sought to determine the effect of ZNE on the adhesion of VSMCs to fibronectin. Our results show that the adhesion of HASMCs to extracellular matrix, assessed using fibronectin-coated plates, showed that pretreatment with ZNE significantly inhibited adhesion to fibronectin in a concentration-dependent manner (Figure 3).

4.2. ZNE Inhibits TNF-α- and FBS-Evoked Invasion and MMP-2 and MMP-9 Secretion in HASMCs

Inflammatory cytokines, including TNF-α, are known to trigger invasion of HASMCs mediated by matrix metalloproteinases [16, 17]. Our results here show that treatment with ZNE (100 and 150 μg/ml) inhibited HASMC invasion of the Matrigel-coated filter inserts. ZNE significantly reduced invasion by 25% and 50% at concentrations 100 and 150 μg/ml, respectively (Figure 4(a)). Levels of MMP-2 and MMP-9 secreted in the conditioned media of HASMCs exposed to TNF-α in the absence and presence of ZNE were assessed with ELISA. Similar experiments were conducted in VSMCs exposed to different concentrations of ZNE in FBS-supplemented media. In accordance with the results of cell invasion assays, ZNE, at 100, 150, and 200 μg/ml concentrations, significantly reduced MMP-2 (Figures 4(b) and 4(c)) and MMP-9 (Figures 4(d) and 4(e)) secretion in a time- and concentration-dependent manner.

4.3. ZNE Inhibits TNF-α-Induced Adhesion of Monocytes to Endothelial and Smooth Muscle Cells

Monocyte adhesion is a hallmark of atherosclerosis. In order to investigate the effect of ZNE on monocyte adhesion to TNF-α-activated endothelial or smooth muscle cells, THP-1 cells were incubated with TNF-α-treated HUVECs or HASMCs, with or without prior exposure to increasing concentrations of ZNE. In the absence of TNF-α stimulation, no or minimal number of monocytes adhered to HASMCs or HUVECs (Figures 5(a) and 5(b), respectively). However, a clear and significant increase in monocyte adhesion was observed following TNF-α treatment. Pretreatment with ZNE decreased monocyte adhesion on the TNF-α-activated cells in a concentration-dependent manner (Figure 5).

4.4. ZNE Inhibited TNF-α-Induced ICAM-1 and VCAM-1 Expression in Endothelial Cells

The interaction of endothelial cells and monocytes in atherosclerosis is mediated through adhesion molecules, among which are VCAM-1 [18] and ICAM-1 [19]. The effect of ZNE on the expression of ICAM-1 and VCAM-1 in TNF-α-stimulated HUVECs was examined on the protein and mRNA levels. TNF-α treatment of HUVECs showed ~3-fold increase in VCAM-1 (Figure 6(a)) and ICAM-1 (Figure 6(b)) protein expression levels compared to untreated controls in cell surface ELISA assays. However, pretreatment with ZNE decreased the ICAM-1 and the VCAM-1 protein expression in the TNF-α-activated HUVECs in a concentration-dependent manner to a level that is similar to the control values (Figure 6). A similar effect was observed in RT-PCR assays on the ICAM-1 and VCAM-1 transcripts (data not shown).

4.5. ZNE Inhibits TNF-α-Induced Expression of NF-κB in a Concentration-Dependent Manner

Several atherogenic stimuli converge at the NF-κB signaling pathway. TNF-α activates NF-κB transcription factor translocation to the nucleus with subsequent activation of the transcription of many genes, including adhesion molecules [20]. Whether ZNE affected the transcription of adhesion molecules through NF-κB pathway was tested using luciferase assay. As shown in Figure 7, HUVECs treated with TNF-α showed considerable increase in NF-κB expression. However, this was reversed by preexposure of TNF-α-activated HUVECs to increasing concentrations of ZNE in a concentration-dependent manner.

5. Discussion

Pathological alternation of VSMCs is a main player in atheroma progression [21]. VSMCs lose their ability to regulate vasocontraction and switch to a synthetic phenotype in response to inflammatory signals [22]. Locally produced growth factors and cytokines stimulate the migration of VSMCs into the intima and the subsequent proliferation. These migrated VSMCs synthesize ECM proteins that can stabilize the atherosclerotic plaque [22]. Consequently, inhibiting the proliferation and migration of VSMCs would confer a beneficial effect in atherosclerosis prevention. Moreover, VSMCs secrete MMP-2 and MMP-9 enzymes that can degrade the extracellular matrix enabling leukocyte influx, thinning of the fibrous cap and angiogenesis [23]. In vivo studies showed that MMP-9 regulates both VSMC migration and invasion [24].

Here, we showed that the ethanolic extract of Z. nummularia inhibited key events that are integral to the process of atherosclerosis. Indeed, ZNE inhibited FBS-induced proliferation as well as the migration of human aortic smooth muscle cells. Adhesion to fibronectin, an extracellular protein, was also inhibited by ZNE. Importantly, these inhibited activities were concomitant with decreased production of metalloproteases (MMP-2 and MMP-9) as well as diminished invasive capacity of these cells.

Ziziphus nummularia, family Rhamnaceae, is native to India, Pakistan, and Iran but is also widely found in the deserts of the Arabian Peninsula. It is widely used in folk medicine of various countries (Iran, India, Pakistan, and others) as a treatment for a wide spectrum of ailments such as cold, cough, throat inflammation, and diabetes as well as a sedative, aphrodisiac, and an antiseptic [25, 26]. A recent study identified a new terpene isolated from Z. nummularia that appears to possess potent anticancer activity, both in vitro and in vivo [26]. Relevantly, the leaves of Z. nummularia have been recently shown to elicit an anti-inflammatory effect [6]. It is this anti-inflammatory capacity that is attractive and desirable for the potential utilization of this herb in the treatment or management of atherosclerosis. Here, we studied the effects of Ziziphus nummularia on TNF-α-activated HUVECs and HASMCs, an inflammation model mimicking atherogenesis. We found that the ethanolic extract of this plant significantly inhibited the migration and invasion of VSMCs as wells as the adhesion of monocytes on endothelial and smooth muscle cells. These results provide indications for a potential antiatherogenic effect of Ziziphus nummularia as a potential herbal supplement, provided that further studies support its safety.

To the best of our knowledge, this is the first study that investigated the atheromodulatory effects of Ziziphus nummularia. However, other Ziziphus species have been reported to possess antiatherosclerotic properties. Zizyphusjujuba contains a variety of triterpenoids that inhibit foam cell formation in macrophages [27]. Also, polyphenols extracted from Zizyphus jujuba peels have the potential to prevent isoproterenol-induced myocardial injury [28]. It was also shown that Z. jujuba extract can block vascular angiogenesis by inhibiting endothelial MMP-2 production [29]. Ziziphus oenoplia is another member of Rhamnaceae family that is suggested to possess antiatherosclerotic properties. The ethanolic extract of Ziziphus oenoplia demonstrated hypolipidemic activity in vivo [30]. Moreover, Ziziphus spina-christi leaf powder has significantly inhibited hyperlipidemia in high-cholesterol-fed rats [31].

The leaves of Ziziphus nummularia are rich in tannins, flavonoids, steroids, glycosides, and alkaloids [7]. Interestingly, tannins were demonstrated to inhibit proliferation and migration of HASMCs [32, 33]. Being a constituent of Ziziphus nummularia extract, tannins may be imparting these antiproliferative and antimigratory effects; however, this remained to be established. Importantly, the decrease in HASMC migration and invasion was coupled to a reduced MMP-9 and MMP-2 expression, providing a potential mechanism to underlie the effect of ZNE. To the best of our knowledge, this is the first report to show reduced cellular migration and invasion by any species of the Ziziphus genus; hence, this is the significance of our findings.

In the context of atherosclerosis, the binding of VSMCs to fibronectin is of marked importance since fibronectin is known to modulate arterial smooth muscle cell dedifferentiation from a contractile phenotype to a synthetic one [34]. Indeed, it has long been established that fibronectin plays key roles in the adhesion, proliferation, differentiation, and migration of different cell types [35]. The main fibronectin receptor that is abundantly expressed on the surface of VSMCs is α5β1 [36]. Importantly, the upregulation of α5β1 integrin in the neointimal lumen is thought to critically augment VSMCs adhesion to fibronectin during inflammation [36]. With a suggested role in fibrin adhesion and fibrin clot formation [37], α5β1 could contribute to luminal narrowing of the vessel because of the abundancy of both fibrin and fibronectin in the atherosclerotic lesion [38]. Our results showed that the treatment of HASMCs with ZNE significantly inhibited their fibronectin adhesive capacity. Whether the effect of ZNE on fibronectin adhesion is through α5β1 modulation in HASMCs remains to be validated.

Plaque formation is precipitated by various irritants, such as increased lipid levels in dyslipidemia or elevated systemic blood pressure in hypertension. These irritants can act as insults that compromise the endothelial integrity resulting in the accumulation of low-density lipoproteins (LDL) in the sub-endothelial space [39, 40]. The oxidation of these trapped LDL can then lead to a series of events, including an increased expression of adhesion molecules [39, 40]. These molecules then promote the interaction between monocytes and endothelial cells during the early stages of atherosclerosis [41]. Indeed, when monocytes bind to these adhesion molecules, they are redirected into the intima by the proinflammatory milieu. Monocytes get attracted to and accumulate in the subendothelial space where they take up lipids to become foam cells [42]. This leads to plaque formation and thickening of the vessel wall due to accumulation of foam cells, VSMCs, and other cell types [42]. In order to determine if ZNE modulates these adhesion molecules, we utilized TNF-α to mimic inflammatory stimuli. Indeed, pretreatment of TNF-α-activated HUVECs with ZNE led to a significant reduction of monocyte adhesion. Since the interaction between endothelial cells and monocytes or monocyte-derived cells is mediated through adhesion molecules [39, 40] and the upregulation of these molecules is intimately associated with atherosclerosis-prone aortas [39, 40], we examined the effect of ZNE on the expression of two molecules of this family, namely, ICAM-1 and VCAM-1. These two proteins are known to show increased expression on the intimal side of the atherosclerotic plague endothelia but not the adventitial side [43]. Here, we showed that ZNE decreased the expression of both ICAM-1 and VCAM-1 in TNF-α-activated endothelial cells on both RNA and protein levels. Thus, one could postulate that this decrease in monocyte adhesion, likely due to reduced adhesion molecules expression, could help in reversing atherosclerosis at its early stages.

NF-κB is a transcription factor that lies at the crossroads of inflammation and atherogenesis [44]. It regulates proteins that play a key role in the pathogenesis of atherosclerosis. Some of these proteins are ICAM-1, VCAM-1, MMP-2, and MMP-9 [45, 46]. Importantly, the critical roles that NF-κB plays are evident in virtually all stages of atherosclerosis, including vascular remodeling, plaque formation, and fatal plaque rupture [44]. In an unstimulated state, NF-κB activity is suppressed by the inhibitor protein, IκB. Several stimuli, including TNF-α, activate NF-κB through a series of signaling cascades leading to IκB phosphorylation, which then allows for NF-κB release and nuclear translocation triggering the transcription of atherogenic genes. Our results here show that ZNE decreased NF-κB expression in TNF-α-activated endothelial cells providing a molecular context for the observed antiatherogenic effects of ZNE on VCAM-1, ICAM-1, MMP-2, and MMP-9. Interestingly, recent in silico studies showed that a component of Ziziphus nummularia can bind to and inhibit the production of TNF-α in activated macrophages [9]. This compound, however, was purified from the root bark of Z. nummularia; whether it also exists in the leaves remains to be established. This finding supports the potential antiatherosclerotic effects of Ziziphus nummularia and identifies a possible pathway by which it elicits these effects.

6. Conclusions

In summary, our results showed that the ethanolic extract of Ziziphus nummularia leaves has antiatherogenic properties. By inhibiting the inflammation-induced proliferation, migration, invasion, and fibronectin adhesion of HASMCs, as well as reducing reduced VCAM-1 and ICAM-1 expression in endothelial cells, Z. nummularia imparts its antiatherosclerotic effects. Ongoing and future studies will focus on isolating and characterizing the effects of the bioactives of the ethanolic extracts as well as the evaluation of the effect of Ziziphus nummularia on the aspects of blood vessel function animal models of vascular inflammation.

Conflicts of Interest

The authors declare that there is no conflict of interest regarding the publication of this article.

Authors’ Contributions

Manal Fardoun and Tuqa Al-Shehabi contributed equally to this work.


This publication was made possible by Grant #/UREP no.16-147-1-022 from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors.


  1. T. Saleh Al-Shehabi, R. Iratni, and A. H. Eid, “Anti-atherosclerotic plants which modulate the phenotype of vascular smooth muscle cells,” Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, vol. 23, no. 11, pp. 1068–1081, 2016. View at: Publisher Site | Google Scholar
  2. G. Douglas and K. M. Channon, “The pathogenesis of atherosclerosis,” Medicine, vol. 38, no. 8, pp. 397–402, 2010. View at: Publisher Site | Google Scholar
  3. T. Wang, D. Palucci, K. Law, B. Yanagawa, J. Yam, and J. Butany, “Atherosclerosis: pathogenesis and pathology,” Diagnostic Histopathology, vol. 18, no. 11, pp. 461–467, 2012. View at: Publisher Site | Google Scholar
  4. A. C. Doran, N. Meller, and C. A. McNamara, “Role of smooth muscle cells in the initiation and early progression of atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 5, pp. 812–819, 2008. View at: Publisher Site | Google Scholar
  5. M. Ullah, M. U. Khan, A. Mahmood et al., “An ethnobotanical survey of indigenous medicinal plants in Wana district south Waziristan agency, Pakistan,” Journal of Ethnopharmacology, vol. 150, no. 3, pp. 918–924, 2013. View at: Publisher Site | Google Scholar
  6. M. Goyal, M. Ghosh, B. P. Nagori, and D. Sasmal, “Analgesic and anti-inflammatory studies of cyclopeptide alkaloid fraction of leaves of Ziziyphus nummularia,” Saudi Journal of Biological Sciences, vol. 20, no. 4, pp. 365–371, 2013. View at: Publisher Site | Google Scholar
  7. R. P. Bodroth and M. Das, “Phytochemical screening and antimicrobial activity of ethanol and chloroform extract of Zizyphus nummularis Wt. & Arm,” African Journal of Biotechnology, vol. 11, no. 21, pp. 4929–4933, 2012. View at: Google Scholar
  8. H. S. Yusufoglu, “Topical anti-inflammatory and wound healing activities of herbal gel of Ziziphus nummularia L. (F. Rhamnaceae) leaf extract,” International Journal of Pharmacology, vol. 7, no. 8, pp. 862–867, 2011. View at: Google Scholar
  9. S. D. Ray, S. Ray, M. Zia-Ul-Haq, V. De Feo, and S. Dewanjee, “Pharmacological basis of the use of the root bark of Zizyphus nummularia Aubrev. (Rhamnaceae) as anti-inflammatory agent,” BMC Complementary and Alternative Medicine, vol. 15, no. 1, p. 416, 2015. View at: Publisher Site | Google Scholar
  10. A. G. Dureja and K. Dhiman, “Free radical scavenging potential and total phenolic and flavonoid content of Ziziphus mauritiana and Ziziphus nummularia fruit extracts,” International Journal of Green Pharmacy, vol. 6, no. 3, pp. 187–192, 2012. View at: Publisher Site | Google Scholar
  11. S. Rajasekaran, B. Jaykar, R. Anandan, K. P. Aboobacker, and S. Vannamalar, “Anti-diabetic activity of leaves of Zizyphus nummularia by dexamethasone induced diabetic rat model,” International Journal of PharmTech Research, vol. 5, no. 2, pp. 844–851, 2013. View at: Google Scholar
  12. S. Horigome, I. Yoshida, S. Ito et al., “Inhibitory effects of Kaempferia parviflora extract on monocyte adhesion and cellular reactive oxygen species production in human umbilical vein endothelial cells,” European Journal of Nutrition, vol. 56, no. 3, pp. 949–964, 2017. View at: Publisher Site | Google Scholar
  13. I. Manduteanu, M. Voinea, F. Antohe et al., “Effect of enoxaparin on high glucose-induced activation of endothelial cells,” European Journal of Pharmacology, vol. 477, no. 3, pp. 269–276, 2003. View at: Publisher Site | Google Scholar
  14. A. H. Eid, K. Maiti, S. Mitra et al., “Estrogen increases smooth muscle expression of alpha2C-adrenoceptors and cold-induced constriction of cutaneous arteries,” American Journal of Physiology Heart and Circulatory Physiology, vol. 293, no. 3, pp. H1955–H1961, 2007. View at: Publisher Site | Google Scholar
  15. A. H. Eid, M. A. Chotani, S. Mitra, T. J. Miller, and N. A. Flavahan, “Cyclic AMP acts through Rap1 and JNK signaling to increase expression of cutaneous smooth muscle alpha2C-adrenoceptors,” American Journal of Physiology Heart and Circulatory Physiology, vol. 295, no. 1, pp. H266–H272, 2008. View at: Publisher Site | Google Scholar
  16. Q. Cao, Y. Jiang, J. Shi et al., “Artemisinin inhibits the proliferation, migration, and inflammatory reaction induced by tumor necrosis factor-alpha in vascular smooth muscle cells through nuclear factor kappa B pathway,” The Journal of Surgical Research, vol. 194, no. 2, pp. 667–678, 2015. View at: Publisher Site | Google Scholar
  17. Y. Zhong, W. Yu, J. Feng, Z. Fan, and J. Li, “Curcumin suppresses tumor necrosis factor-alpha-induced matrix metalloproteinase-2 expression and activity in rat vascular smooth muscle cells via the NF-kappaB pathway,” Experimental and Therapeutic Medicine, vol. 7, no. 6, pp. 1653–1658, 2014. View at: Publisher Site | Google Scholar
  18. R. E. Gerszten, Y. C. Lim, H. T. Ding et al., “Adhesion of monocytes to vascular cell adhesion molecule-1-transduced human endothelial cells: Implications for atherogenesis,” Circulation Research, vol. 82, no. 8, pp. 871–8, 1998. View at: Publisher Site | Google Scholar
  19. A. Rahman and F. Fazal, “Hug tightly and say goodbye: role of endothelial ICAM-1 in leukocyte transmigration,” Antioxidants & Redox Signaling, vol. 11, no. 4, pp. 823–839, 2009. View at: Publisher Site | Google Scholar
  20. H. J. Sun, M. X. Zhao, T. Y. Liu et al., “Salusin-beta induces foam cell formation and monocyte adhesion in human vascular smooth muscle cells via miR155/NOX2/NFkappaB pathway,” Scientific Reports, vol. 6, p. 23596, 2016. View at: Publisher Site | Google Scholar
  21. R. J. Frink, The Smooth Muscle Cell. The Pivot in Atherosclerosis. Inflammatory Atherosclerosis: Characteristics of the Injurious Agent, Heart Research Foundation, Sacramento (CA), 2002.
  22. A. Rudijanto, “The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis,” Acta Medica Indonesiana, vol. 39, no. 2, pp. 86–93, 2007. View at: Google Scholar
  23. M. Schafers, O. Schober, and S. Hermann, “Matrix-metalloproteinases as imaging targets for inflammatory activity in atherosclerotic plaques,” Journal of Nuclear Medicine, vol. 51, no. 5, pp. 663–666, 2010. View at: Publisher Site | Google Scholar
  24. Z. S. Galis, C. Johnson, D. Godin et al., “Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling,” Circulation Research, vol. 91, no. 9, pp. 852–9, 2002. View at: Publisher Site | Google Scholar
  25. M. P. Khan, M. Ahmad, M. Zafar, S. Sultana, M. I. Ali, and H. Sun, “Ethnomedicinal uses of edible wild fruits (EWFs) in Swat Valley, Northern Pakistan,” Journal of Ethnopharmacology, vol. 173, pp. 191–203, 2015. View at: Publisher Site | Google Scholar
  26. S. D. Ray and S. Dewanjee, “Isolation of a new triterpene derivative and in vitro and in vivo anticancer activity of ethanolic extract from root bark of Zizyphus nummularia Aubrev,” Natural Product Research, vol. 29, no. 16, pp. 1529–1536, 2015. View at: Publisher Site | Google Scholar
  27. Y. Fujiwara, A. Hayashida, K. Tsurushima et al., “Triterpenoids isolated from Zizyphus jujuba inhibit foam cell formation in macrophages,” Journal of Agricultural and Food Chemistry, vol. 59, no. 9, pp. 4544–4552, 2011. View at: Publisher Site | Google Scholar
  28. D. Cheng, C. Zhu, J. Cao, and W. Jiang, “The protective effects of polyphenols from jujube peel (Ziziphus jujube Mill) on isoproterenol-induced myocardial ischemia and aluminum-induced oxidative damage in rats,” Food and Chemical Toxicology, vol. 50, no. 5, pp. 1302–1308, 2012. View at: Publisher Site | Google Scholar
  29. S. W. Kang, J. S. Choi, J. Y. Bae et al., “Blockade of vascular angiogenesis by Aspergillus usamii var. shirousamii-transformed Angelicae Gigantis Radix and Zizyphus jujuba,” Nutrition Research and Practice, vol. 3, no. 1, pp. 3–8, 2009. View at: Publisher Site | Google Scholar
  30. M. L. Eswari, R. V. Bharathi, and N. Jayshree, “Hypolipidemic activity on ethanolic extract of leaves of Ziziphus oenoplia (L) Mill. Gard,” International Journal of Pharmaceutical & Biological Archives, vol. 4, no. 1, pp. 136–141, 2013. View at: Google Scholar
  31. H. A. El Rabey, E. S. Attia, M. N. Al-Seeni et al., “The hypolipidemic and antioxidant activity of Christ’s thorn (Ziziphus spina-christi) leaves powder in hypercholesterolemic male rats,” Life Science Journal, vol. 11, no. 10, pp. 1010–1021, 2014. View at: Google Scholar
  32. H. Zargham and R. Zargham, “Tannin extracted from sumac inhibits vascular smooth muscle cell migration,” McGill Journal of Medicine, vol. 11, no. 2, pp. 119–123, 2008. View at: Google Scholar
  33. L. Wang, L. H. Zhu, H. Jiang et al., “Grape seed proanthocyanidins attenuate vascular smooth muscle cell proliferation via blocking phosphatidylinositol 3-kinase-dependent signaling pathways,” Journal of Cellular Physiology, vol. 223, no. 3, pp. 713–726, 2010. View at: Publisher Site | Google Scholar
  34. U. Hedin, B. A. Bottger, E. Forsberg, S. Johansson, and J. Thyberg, “Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells,” The Journal of Cell Biology, vol. 107, no. 1, pp. 307–319, 1988. View at: Publisher Site | Google Scholar
  35. E. Ruoslahti, “Fibronectin and its receptors,” Annual Review of Biochemistry, vol. 57, no. 1, pp. 375–413, 1988. View at: Publisher Site | Google Scholar
  36. J. G. Pickering, L. H. Chow, S. Li et al., “alpha5beta1 integrin expression and luminal edge fibronectin matrix assembly by smooth muscle cells after arterial injury,” The American Journal of Pathology, vol. 156, no. 2, pp. 453–465, 2000. View at: Publisher Site | Google Scholar
  37. K. O. Yee, M. M. Rooney, C. M. Giachelli, S. T. Lord, and S. M. Schwartz, “Role of beta1 and beta3 integrins in human smooth muscle cell adhesion to and contraction of fibrin clots in vitro,” Circulation Research, vol. 83, no. 3, pp. 241–251, 1998. View at: Publisher Site | Google Scholar
  38. H. C. Stary, A. B. Chandler, R. E. Dinsmore et al., “A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, no. 9, pp. 1512–1531, 1995. View at: Publisher Site | Google Scholar
  39. P. Libby, “Inflammation in atherosclerosis,” Nature, vol. 420, no. 6917, pp. 868–874, 2002. View at: Publisher Site | Google Scholar
  40. P. Libby, P. M. Ridker, and A. Maseri, “Inflammation and atherosclerosis,” Circulation, vol. 105, no. 9, pp. 1135–1143, 2002. View at: Publisher Site | Google Scholar
  41. J. Mestas and K. Ley, “Monocyte-endothelial cell interactions in the development of atherosclerosis,” Trends in Cardiovascular Medicine, vol. 18, no. 6, pp. 228–232, 2008. View at: Publisher Site | Google Scholar
  42. D. A. Chistiakov, Y. V. Bobryshev, and A. N. Orekhov, “Macrophage-mediated cholesterol handling in atherosclerosis,” Journal of Cellular and Molecular Medicine, vol. 20, no. 1, pp. 17–28, 2016. View at: Publisher Site | Google Scholar
  43. K. D. O’Brien, T. O. McDonald, A. Chait, M. D. Allen, and C. E. Alpers, “Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content,” Circulation, vol. 93, no. 4, pp. 672–682, 1996. View at: Publisher Site | Google Scholar
  44. I. Pateras, C. Giaginis, C. Tsigris, E. Patsouris, and S. Theocharis, “NF-kappaB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links,” Expert Opinion on Therapeutic Targets, vol. 18, no. 9, pp. 1089–1101, 2014. View at: Publisher Site | Google Scholar
  45. I. Kim, S. O. Moon, S. H. Kim, H. J. Kim, Y. S. Koh, and G. Y. Koh, “Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells,” The Journal of Biological Chemistry, vol. 276, no. 10, pp. 7614–7620, 2001. View at: Publisher Site | Google Scholar
  46. B. Pamukcu, G. Y. Lip, and E. Shantsila, “The nuclear factor—kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease,” Thrombosis Research, vol. 128, no. 2, pp. 117–123, 2011. View at: Publisher Site | Google Scholar

Copyright © 2017 Manal Fardoun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

1417 Views | 483 Downloads | 7 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.